New report finds that just 13% of IP-owning firms have sought financing through their assets, with billions in potential ...
10 April 2026 The 2026 panel has been chosen. With judges from Amgen, Pfizer, Eli Lilly, Takeda, Regeneron and law firms such ...
The panel has been chosen. With judges from Amgen, Pfizer, Eli Lilly, Takeda, Regeneron and law firms such as White & Case and Arnold & Porter, here’s who will be deciding this year’s winners.
The firm has added two partners to its government and regulatory team, bringing expertise in FDA matters, product approvals, ...
In light of Emotional Perception AI, the UKIPO has rewritten the rules for “mixed inventions". Matt Jefferies and Eric McNeil ...
The acquisition of Munich-based biotech gives Gilead ownership of proprietary ADCs tech at a time when pharma and biotech ...
On World Health Day 2026, despite data trending in the right direction, systemic barriers continue to limit female inventors—and women's health is suffering. Already registered?
According to the settlement, MSN can maintain its challenge to several Bausch patents, while the details around potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results